Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis, 1873-5835

Journal

More filtering options
  1. Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol

    Barbany, G., Andersen, M. K., Autio, K., Borgstrom, G., Franco, L. C., Golovleva, I., Heim, S., Heinonen, K., Hovland, R., Bertil Johansson, Johannsson, J. H., Kjeldsen, E., Nordgren, A., Palmqvist, L. & Forestier, E., 2012, In : Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis. 36, 7, p. 936-938

    Research output: Contribution to journalLetter

  2. Trisomy 19 as the sole chromosomal abnormality in proliferative chronic myelomonocytic leukemia

    Daskalakis, M., Mauritzson, N., Bertil Johansson, Bouabdallah, K., Onida, F., Kunzmann, R., Mueller-Berndorff, H., Schmitt-Graeff, A. & Luebbert, M., 2006, In : Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis. 30, 8, p. 1043-1047

    Research output: Contribution to journalArticle

  3. Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy

    Groevdal, M., Kahn, R., Jansson, M., Aggerholm, A., Antunovic, P., Jan Astermark, Bernell, P., Engstroem, L., Kjeldsen, L., Linder, O., Nilsson, L., Olsson, A., Skovholm, M. & Tangen, J., 2009, In : Leukemia Research. 33, Suppl 1, p. S49-S50

    Research output: Contribution to journalPublished meeting abstract

  4. Expression of p53 or cytoplasmic nucleophosmine associated with increased risk of disease progression in myelodysplastic syndrome with isolated del(5q)

    Jadersten, M., Saft, L., Garelius, H., Hast, R., Nilsson, L., Samuelsson, J., Porwit, A. & Hellstrom-Lindberg, E., 2009, In : Leukemia Research. 33, p. S39-S39

    Research output: Contribution to journalPublished meeting abstract

  5. Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia

    Kaderi, M. A., Mansouri, M., Zainuddin, N., Cahill, N., Rebeqa Gunnarsson, Jansson, M., Kimby, E., Aleskog, A., Lundin, J., Glimelius, B., Melbye, M., Gunnar Juliusson, Jurlander, J. & Rosenquist, R., 2010, In : Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis. 34, 3, p. 335-339

    Research output: Contribution to journalArticle

  6. The GNAS1 T393C polymorphism and lack of clinical prognostic value in chronic lymphocytic leukemia

    Kaderi, M. A., Murray, F., Jansson, M., Merup, M., Karlsson, K., Ross, G., Aleskog, A. & Tobin, G., 2008, In : Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis. 32, 6, p. 984-987

    Research output: Contribution to journalArticle

Previous 1 2 3 Next